NONSEGMENTAL VITILIGO (STABLE)

Clinical trials for NONSEGMENTAL VITILIGO (STABLE) explained in plain language.

Never miss a new study

Get alerted when new NONSEGMENTAL VITILIGO (STABLE) trials appear

Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO (STABLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New skin pigment drug tested for vitiligo treatment

Disease control Recruiting now

This study is testing whether adding an investigational drug called Melanotan II to standard narrowband UV-B light therapy helps restore skin color in adults with stable vitiligo. Sixty participants will receive either the drug or a placebo along with light therapy for 24 weeks. …

Matched conditions: NONSEGMENTAL VITILIGO (STABLE)

Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NONSEGMENTAL VITILIGO (STABLE)

Get alerted when new NONSEGMENTAL VITILIGO (STABLE) trials appear

New skin pigment drug tested for vitiligo treatment